Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Sekisui Diagnostics

Download Mobile App




Enzyme Therapy Lowers Blood Pressure

By LabMedica International staff writers
Posted on 28 Dec 2009
Cardiovascular disease researchers working with a mouse model have demonstrated a novel therapy for reducing hypertension.

Current hypertension therapies such as ACE (angiotensin converting enzyme) inhibitors block the formation of angiotensin II, a protein that causes blood vessels to constrict and increases blood pressure. More...
In the current study, investigators at Northwestern University (Chicago, IL, USA) worked with a human recombinant form of angiotensin (Ang)-converting enzyme 2 (ACE2), which breaks down Ang II to form the peptide Ang-(1-7).

They reported in the January 2010 online edition of the journal Hypertension that infusing the recombinant enzyme (rACE2) into mice caused a dose-dependent increase in serum ACE2 activity but had no effect on kidney or cardiac ACE2 activity. The presence of rACE2 in the blood of the mice prevented the rapid hypertensive effect of injected Ang II, and this was associated with both a decrease in Ang II and an increase in Ang-(1-7) in plasma. During Ang II infusion, rACE2 effectively degraded Ang II and, in the process, normalized blood pressure. The mechanism of rACE2 action resulted from an increase in systemic, not tissue, ACE2 activity and the lowering of plasma Ang II rather than the attendant increase in Ang-(1-7).

"This therapeutic approach can also be superior to existing therapies that block the activity of the renin-angiotensin system, but only partially, and therefore, provide a more complete and effective suppression of this system to treat not just hypertension but many other medical conditions where angiotensin II over activity is undesirable," said senior author Dr. Daniel Batlle, professor of medicine at the Northwestern University.

Related Links:

Northwestern University




Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
Gold Member
Blood-Based Protein Biomarker Solution for Alzheimer's Disease
BG-DTi2000.
Platinum Member
Integrated Biochemical & Immunological System
Biolumi CX Solution X10+C10
HPV Test
Allplex HPV28 Detection
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image Credit: 123RF

Screening After Pneumococcal Disease May Reveal Undiagnosed Blood Cancer or Immune Disorders

Severe pneumococcal disease requiring hospitalization often presents as pneumonia, particularly in older adults and people with cancer or compromised immune function. Because M protein testing and antibody... Read more

Microbiology

view channel
Image Credit: 123RF

FDA-Cleared Multiplex PCR Test Detects 13 Respiratory Pathogens in a Single Sample

Respiratory tract infections can be difficult to distinguish at presentation because many cause overlapping, nonspecific symptoms and are initially grouped as influenza-like illnesses. Causes span a range... Read more

Technology

view channel
Image: The laser-based photoacoustic spectroscopy setup consists of a Mid-IR laser equipped with three QCL modules covering wavelengths from 5.6 μm to 12.9 μm, two silver coated mirrors (SCM), a dichroic mirror (DM) with a transmittance of 90%, a thermal power sensor head (PM) to monitor the output laser power, a mechanical chopper (MC) for frequency modulation and a CEPAS-detector with a self-designed swab holder (SH). (Credit: Graunke, T., Scholz, T., Pieniak, M. et al. Scientific Reports (2026). https://doi.org/10.1038/s41598-026-68298-9)

Laser-Based Swab Analysis Shows Promise for Detecting Disease-Linked Odor Patterns

Disease-related changes in volatile organic compounds can alter body odor, producing measurable patterns in exhaled breath and bodily fluids. Current analytical methods can be complex, time-consuming,... Read more

Industry

view channel
Image

Collaboration Combines AI Cognitive Assessment and RNA Blood Testing for Earlier Alzheimer’s Detection

Alzheimer’s disease is often identified only after substantial neurodegeneration, partly because current diagnostic pathways are fragmented and difficult to scale. As treatment shifts toward earlier intervention,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.